252 related articles for article (PubMed ID: 6838557)
1. Conversion of 3H-PAF acether by rabbit platelets is independent from aggregation: evidences for a novel metabolite.
Touqui L; Jacquemin C; Vargaftig BB
Biochem Biophys Res Commun; 1983 Feb; 110(3):890-3. PubMed ID: 6838557
[TBL] [Abstract][Full Text] [Related]
2. Paf-acether formation and arachidonic acid freeing from platelet ether-linked glyceryl-phosphorylcholine.
Chignard M; Le Couedic JP; Coëffier E; Benveniste J
Biochem Biophys Res Commun; 1984 Oct; 124(2):637-43. PubMed ID: 6437404
[TBL] [Abstract][Full Text] [Related]
3. 1-O-alkyl-2-acyl-sn-glycero-3-phosphorylcholine is the precursor of platelet-activating factor in stimulated rabbit platelets. Evidence for an alkylacetyl-glycerophosphorylcholine cycle.
Touqui L; Jacquemin C; Dumarey C; Vargaftig BB
Biochim Biophys Acta; 1985 Jan; 833(1):111-8. PubMed ID: 3967037
[TBL] [Abstract][Full Text] [Related]
4. The role of Ca2+ in regulating the catabolism of PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) in rabbit platelets.
Touqui L; Shaw AM; Dumarey C; Jacquemin C; Vargaftig BB
Biochem J; 1987 Jan; 241(2):555-60. PubMed ID: 3109377
[TBL] [Abstract][Full Text] [Related]
5. Dissociation between inhibition of phospholipid methylation and production of PAF-acether by rabbit platelets.
Touqui L; Chignard M; Jacquemin C; Wal F; Vargaftig BB
Experientia; 1984 Apr; 40(4):374-7. PubMed ID: 6714369
[TBL] [Abstract][Full Text] [Related]
6. Specific binding of [3H]-1-O-octadecyl Paf-acether to washed human platelets.
Tuffin DP; Davey P; Dyer RL; Lunt DO; Wade PJ
Adv Exp Med Biol; 1985; 192():83-96. PubMed ID: 3834789
[TBL] [Abstract][Full Text] [Related]
7. Transient activation of the acetyltransferase necessary for paf-acether biosynthesis in thrombin-activated platelets.
Coëffier E; Ninio E; Le Couedic JP; Chignard M
Br J Haematol; 1986 Apr; 62(4):641-51. PubMed ID: 3964558
[TBL] [Abstract][Full Text] [Related]
8. Binding kinetics of PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) to intact human platelets.
Kloprogge E; Akkerman JW
Biochem J; 1984 Nov; 223(3):901-9. PubMed ID: 6150705
[TBL] [Abstract][Full Text] [Related]
9. Effect of structural analogues of PAF-acether on platelet desensitization.
Keraly CL; Coëffier E; Tencé M; Borrel MC; Benveniste J
Br J Haematol; 1983 Mar; 53(3):513-21. PubMed ID: 6824590
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of transmembrane movement and metabolism of platelet activating factor (PAF-acether) by a specific antagonist, BN 52021.
Lachachi H; Plantavid M; Simon MF; Chap H; Braquet P; Douste-Blazy L
Biochem Biophys Res Commun; 1985 Oct; 132(2):460-6. PubMed ID: 2998370
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic study of 3H-labelled PAF-acether II. Comparison with 3H-labelled lyso-PAF-acether after intravenous administration in the rabbit and protein binding.
Lartigue-Mattei C; Godeneche D; Chabard JL; Petit J; Berger JA
Agents Actions; 1984 Dec; 15(5-6):643-8. PubMed ID: 6532184
[TBL] [Abstract][Full Text] [Related]
12. Specific desensitization of rabbit platelets by platelet-activating factor (PAF-acether) and derivatives.
Keraly CL; Benveniste J
Br J Haematol; 1982 Jun; 51(2):313-22. PubMed ID: 7082588
[TBL] [Abstract][Full Text] [Related]
13. [Effects of SIN-1, a metabolite of molsidomine, on paf-acether-blood platelets interactions].
Nunez D; Russo-Marie F; Benveniste J
Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):215. PubMed ID: 3550639
[TBL] [Abstract][Full Text] [Related]
14. Release of platelet-activating factor (PAF-acether) and 2-lyso PAF-acether from three cell types.
Benveniste J; Roubin R; Chignard M; Jouvin-Marche E; Le Couedic JP
Agents Actions; 1982 Dec; 12(5-6):711-3. PubMed ID: 7164945
[TBL] [Abstract][Full Text] [Related]
15. Triggering by Paf-acether and adrenaline of cyclo-oxygenase-independent platelet aggregation.
Fouque F; Vargaftig BB
Br J Pharmacol; 1984 Nov; 83(3):625-33. PubMed ID: 6439269
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of the binding of platelet-activating factor to platelets of different animal species.
Iñarrea P; Gomez-Cambronero J; Nieto M; Crespo MS
Eur J Pharmacol; 1984 Oct; 105(3-4):309-15. PubMed ID: 6510472
[TBL] [Abstract][Full Text] [Related]
17. Antigen-initiated release of platelet-activating factor (PAF-acether) from mouse bone marrow-derived mast cells sensitized with monoclonal IgE.
Mencia-Huerta JM; Lewis RA; Razin E; Austen KF
J Immunol; 1983 Dec; 131(6):2958-64. PubMed ID: 6315819
[TBL] [Abstract][Full Text] [Related]
18. Biosynthesis of platelet-activating factor (PAF-ACETHER). II. Involvement of phospholipase A2 in the formation of PAF-ACETHER and lyso-PAF-ACETHER from rabbit platelets.
Benveniste J; Chignard M; Le Couedic JP; Vargaftig BB
Thromb Res; 1982 Mar; 25(5):375-85. PubMed ID: 6803388
[TBL] [Abstract][Full Text] [Related]
19. Platelet-activating factor (PAF-acether) secretion from platelets: effect of aggregating agents.
Chignard M; Le Couedic JP; Vargaftig BB; Benveniste J
Br J Haematol; 1980 Nov; 46(3):455-64. PubMed ID: 6778498
[TBL] [Abstract][Full Text] [Related]
20. Adrenaline and PAF-acether synergize to trigger cyclooxygenase-independent activation of plasma-free human platelets.
Vargaftig BB; Fouque F; Benveniste J; Odiot J
Thromb Res; 1982 Nov; 28(4):557-73. PubMed ID: 7164036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]